We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Medtronic

Medtronic offers medical products and therapies for the treatment of cardiac and vascular diseases, diabetes, and neu... read more Featured Products: More products

Download Mobile App




Mobile App Warns Diabetics of Dangerous Sugar Levels

By HospiMedica International staff writers
Posted on 14 Jan 2019
A new predictive tool analyzes blood glucose data to determine the likelihood of a hypoglyemic episode within the next several hours.

The Medtronic (Dublin, Ireland) Sugar.IQ app is a personal diabetes assistant with cognitive abilities that uses IBM (Armonk, NY, USA) Watson analytics capabilities to find patterns in diabetes data and offer real-time, personalized diabetes insights by continually analyzing how blood glucose levels respond to food intake, insulin dosages, daily routines, and other factors. More...
Together with the Guardian Connect continuous glucose monitor (CGM), the Sugar.IQ app can turn trend patterns into personalized diabetes care.

Sugar.IQ is powered by the IBM Watson IQcast feature, which uses artificial intelligence (AI) predictive modelling to improve prognostic capabilities over time. A study presented at the last American Diabetes Association Scientific Sessions, which was held in July 2018 in Orlando (FL, USA), showed that Sugar.IQ users are more likely to achieve an extra 36 minutes per day in a healthy glucose range of 70-180 mg/dL, experiencing 30 minutes less time per day in hyperglycemia, and six minutes less daily in hypoglycemia.

“Avoiding complications like hypoglycemia is a tremendous burden, but fortunately it is a problem that can help be alleviated by learning from data, which is where AI comes in,” said Lisa Latts, MD, deputy chief health officer at IBM Watson Health. “Using machine learning models and predictive algorithms, IQcast analyzes multiple signals coming from a user, such as glucose levels, insulin data, food logs, and prior hypoglycemic events to assess whether a user has a low, medium, or high chance of experiencing hypoglycemia within the upcoming four hours.”


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Patient Monitor
IntelliVue MP5SC
New
Short Phlebotomy Cart
MSWA-3469-WHT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: New clinical guidance suggests treatments to prevent blood clots in CLTI patients after leg artery procedures (Photo courtesy of Shutterstock)

Stronger Blood Clot Prevention Measures Needed After Leg Artery Procedures in High-Risk Patients

Chronic limb-threatening ischemia (CLTI), the most severe form of peripheral artery disease (PAD), significantly reduces blood flow to the legs and feet. Despite undergoing lower limb revascularization... Read more

Surgical Techniques

view channel
Image: The milli-spinner can shrink blood clots without rupturing them (Photo courtesy of Andrew Brodhead/Stanford)

New Technology More Than Doubles Success Rate for Blood Clot Removal

In cases of ischemic stroke, where a blood clot obstructs oxygen supply to the brain, time is critical. The faster the clot is removed and blood flow restored, the more brain tissue can be saved, improving... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.